How to Qualify Alternative Packaging Materials Using E&L Data


Published on 03/05/2026

Effective Qualification of Alternative Packaging Materials Through E&L Analysis

In the pharmaceutical industry, the integrity of packaging materials is critical to ensuring product quality and safety. The improper selection of packaging systems can lead to contamination through chemical migration from the materials used, raising concerns regarding extractables and leachables (E&L) studies. These studies are particularly pertinent when qualifying alternative packaging materials. This article aims to equip professionals in manufacturing, quality control, and regulatory affairs with practical approaches to manage E&L risks, ensuring compliance and inspection readiness.

After reading this article, you will be equipped to identify the issues surrounding alternative packaging qualifications, implement effective containment measures, perform thorough investigations, and establish robust corrective and preventive actions to mitigate risks associated with chemical migration.

Symptoms/Signals on the Floor or in the Lab

The need for E&L studies often arises from specific signals observed during product development, batch release, or routine quality assurance checks. Symptoms that indicate potential problems include:

  • Unexpected results in stability testing: Significant deviations in potency, purity, or degradation products may suggest contamination from packaging.
  • Customer
complaints: Reports of compromised product efficacy or safety may highlight issues with packaging materials.
  • Inconsistencies within extractables and leachables profiles: Variability in chemical profiles can call for real-time investigation.
  • Increased failure rates during stability trials: An uptick in product failures under stability conditions may indicate that materials are leaching harmful compounds.
  • Likely Causes

    Understanding potential causes is paramount in addressing E&L concerns. These frame around the categories of Materials, Method, Machine, Man, Measurement, and Environment. Each category may present different challenges:

    Category Likely Cause
    Materials Incompatibility of plasticizers or polymers used in the packaging system.
    Method Improper E&L study protocols not aligned with regulatory expectations (e.g., FDA guidelines).
    Machine Precision failures during the packaging process leading to potential chemical exposure.
    Man Lack of training or awareness about E&L risks among operators and staff.
    Measurement Inaccurate testing methodologies or poor sampling techniques that fail to capture E&L data adequately.
    Environment Improper storage conditions causing material degradation or interaction with solvents.

    Immediate Containment Actions (first 60 minutes)

    When an issue with extractables and leachables is identified, swift containment is vital. Immediate actions should focus on limiting the exposure and assessing the situation:

    1. Isolate affected batches: Withdraw any products suspected of contamination from the distribution chain.
    2. Notify quality control: Engage your quality team to initiate an immediate review of batch records and investigation protocols.
    3. Gather evidence: Begin documenting findings and gather samples of the affected materials for testing.
    4. Implement a quarantine: Place all relevant products in a controlled area until further investigations occur.
    5. Communicate: Inform stakeholders, including regulatory and quality teams, about the anomaly to align response strategies.

    Investigation Workflow (data to collect + how to interpret)

    A methodical approach to investigating concerns surrounding alternative packaging materials is necessary for efficacy. An investigation workflow, with careful attention to detail, includes:

    1. Review batch records: Analyze manufacturing and packaging data to identify any variations or anomalies.
    2. Collect samples: Obtain representative samples of packaging materials and finished products for analysis.
    3. Conduct tests: Implement targeted E&L studies, focusing on extraction and migration assays to evaluate contamination risk.
    4. Consult cross-functional teams: Engage personnel from R&D, quality assurance, and regulatory affairs to gather insights into potential risk factors.
    5. Document findings: Maintain thorough records of all investigative actions and results to support further evaluations and CAPA plans.

    Root Cause Tools (5-Why, Fishbone, Fault Tree) and When to Use Which

    Identifying the underlying causes of issues related to extractables and leachables can be efficiently achieved using various root cause analysis tools:

    1. 5-Why Analysis: This straightforward method is useful when the root cause is not immediately apparent. It encourages deeper questioning to identify the fundamental issue.
    2. Fishbone Diagram: Often employed when analyzing multiple contributing factors, this visual tool helps in categorizing potential causes grouped by materials, methods, and other categories.
    3. Fault Tree Analysis: Ideal for complex scenarios, this deductive reasoning approach breaks down failures in a systematic manner, helping to understand interrelations among various causes.

    CAPA Strategy (Correction, Corrective Action, Preventive Action)

    Once root causes have been identified, implement a CAPA strategy that includes:

    1. Correction: Immediately rectify identified issues such as recalling non-compliant products or ceasing the use of problematic materials.
    2. Corrective Action: Develop a detailed action plan to amend processes that led to the failure. This may involve revising protocols for E&L studies or enhancing material specifications.
    3. Preventive Action: Introduce measures such as routine training for staff, periodic reviews of packaging qualifications, and regular E&L assessments to preempt future occurrences.

    Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

    Establishing a robust control strategy will facilitate ongoing monitoring of the risks associated with packaging materials:

    • Statistical Process Control (SPC): Implement SPC on the extraction and leachables data to identify trends and deviations from acceptable limits.
    • Regular sampling: Set a schedule for routine sampling from production lines to verify compliance with established E&L thresholds.
    • Alerts and alarms: Utilize automation to monitor environmental parameters that could trigger chemical migration.
    • Periodic verification: Conduct regular audits and reviews of E&L testing results to validate ongoing compliance with toxicological thresholds.

    Validation / Re-qualification / Change Control Impact (when needed)

    Changes in packaging materials or processes necessitate careful validation and re-qualification:

    Related Reads

    1. Validation: Engage in validation studies to confirm that alternative materials meet established E&L criteria before commercial use.
    2. Re-qualification: Establish a protocol for re-qualifying materials subjected to changes, ensuring continued compliance with regulatory standards.
    3. Change Control: Implement change control procedures to document any alterations to packaging systems, ensuring all related qualifications follow regulatory requirements.

    Inspection Readiness: What Evidence to Show

    Preparation for potential audits and inspections involves gathering sufficient evidence to demonstrate compliance. Essential documentation includes:

    • Batch records: Comprehensive records detailing manufacturing processes, including E&L analysis results.
    • Investigation logs: Records documenting all findings from investigations related to E&L concerns.
    • CAPA documentation: Evidence of implementation of corrective and preventive actions, along with their effectiveness evaluations.
    • Training records: Proof of staff training on E&L risks and procedures.
    • Supplier assessments: Documentation of supplier audits and evaluations related to the packaging materials used.

    FAQs

    What are extractables and leachables?

    Extractables are compounds that can be extracted from packaging materials under controlled conditions, while leachables are substances that migrate into the product during normal storage conditions.

    How do I ensure compliance for E&L studies?

    Follow regulatory guidelines (e.g., EMA recommendations) and implement a robust testing protocol that includes identification, quantification, and risk assessment of E&L.

    What is the role of toxicology thresholds in E&L studies?

    Toxicology thresholds determine the acceptable limits of leachables in pharmaceutical products, ensuring safety for end-users.

    When should alternative packaging materials be validated?

    Any time a new packaging material is introduced or when current materials are modified or replaced, a validation through E&L studies is necessary.

    What are the common testing methods for E&L?

    Common testing methods include solvent extraction, headspace analysis, and mass spectrometry, designed to detect and quantify potential contaminants.

    How can I assess packaging risk?

    Conduct a thorough packaging risk assessment by analyzing material compatibility, past E&L studies, and potential migration pathways.

    What documentation is critical for readiness for regulatory inspections?

    Maintain detailed batch records, logs of E&L studies, CAPA action plans, and training records to ensure readiness for inspections.

    How do I train my team on E&L risks?

    Implement regular training sessions that incorporate E&L protocols, updates on regulatory compliance, and hands-on workshops to strengthen understanding.

    Pharma Tip:  E&L Studies for Biologics: Adsorption, Aggregation, and Chemical Migration